Study: PET could aid in measuring Huntington's disease progression

08/30/2013 | · (free registration)

A study in The Journal of Clinical Investigation suggests that PET scans can be used to effectively track Huntington's disease progression and could aid in evaluating novel drugs for neurodegenerative disorders before symptoms appear. U.S. researchers said they were able to detect abnormalities in the brains of 12 asymptomatic patients who carry the Huntington's disease gene after subjecting them to a series of PET scans over seven years.

View Full Article in: · (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL